Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2009

01-07-2009 | Epidemiology

The economic burden of breast cancer in California

Authors: Wendy Max, Hai-Yen Sung, Brad Stark

Published in: Breast Cancer Research and Treatment | Issue 1/2009

Login to get access

Abstract

This paper estimates the healthcare costs and the value of lost productivity from premature deaths for California women with breast cancer in 2001, with an updated estimate for 2008. Multiple secondary data sources were used to estimate the healthcare cost of breast cancer. Mortality costs were estimated as the product of the number of deaths and the expected value of a woman’s future earnings. The total economic cost of breast cancer in California was $1.43 billion in 2001, or $1.91 billion in 2008 dollars. Breast cancer is costly both in terms of healthcare dollars and the value of lost lives. Regular screening and access to treatment for all women will allow the disease to be diagnosed earlier, the prognosis improved, and the economic burden reduced.
Literature
1.
go back to reference American Cancer Society, California Division and Public Health Institute, California Cancer Registry (2007) California cancer facts and figures 2008. American Cancer Society, California Division, Oakland, CA American Cancer Society, California Division and Public Health Institute, California Cancer Registry (2007) California cancer facts and figures 2008. American Cancer Society, California Division, Oakland, CA
2.
go back to reference Kwong SL, Perkins CI, Morris CR, Cohen R, Allen M, Wright WE (2001) Cancer in California: 1988–1999. California Department of Health Services, Cancer Surveillance Section, Sacramento, CA Kwong SL, Perkins CI, Morris CR, Cohen R, Allen M, Wright WE (2001) Cancer in California: 1988–1999. California Department of Health Services, Cancer Surveillance Section, Sacramento, CA
3.
go back to reference American Cancer Society, California Division and Public Health Institute, California Cancer Registry (2006) California cancer facts and figures 2007. American Cancer Society, California Division, Oakland, CA American Cancer Society, California Division and Public Health Institute, California Cancer Registry (2006) California cancer facts and figures 2007. American Cancer Society, California Division, Oakland, CA
4.
go back to reference Harris DH, Bates J, Morris CR, Kwong SL, Wright WE (2005) Female breast cancer in California, 2005. California Department of Health Services, Cancer Surveillance Section, Sacramento, CA Harris DH, Bates J, Morris CR, Kwong SL, Wright WE (2005) Female breast cancer in California, 2005. California Department of Health Services, Cancer Surveillance Section, Sacramento, CA
6.
go back to reference Rice D, Hodgson TA (1981) Social and economic implications of cancer in the United States, Vital and Health Statistics, Series 3, No. 20. DHHS Pub. No. (PHS) 81–1404. US Government Printing Office, Washington, DC Rice D, Hodgson TA (1981) Social and economic implications of cancer in the United States, Vital and Health Statistics, Series 3, No. 20. DHHS Pub. No. (PHS) 81–1404. US Government Printing Office, Washington, DC
7.
go back to reference Hodgson TA, Rice DP (1982) Economic impact of cancer in the United States. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention. W.B. Saunders Company, Philadelphia, PA, pp 208–228 Hodgson TA, Rice DP (1982) Economic impact of cancer in the United States. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention. W.B. Saunders Company, Philadelphia, PA, pp 208–228
8.
go back to reference Brown M, Fintor L (1995) The economic burden of cancer. In: Greenwald P, Kramer B, Weed D (eds) Cancer prevention and control. Marcel Dekker, New York Brown M, Fintor L (1995) The economic burden of cancer. In: Greenwald P, Kramer B, Weed D (eds) Cancer prevention and control. Marcel Dekker, New York
10.
go back to reference Rice D, Hodgson T, Capell F (1989) The economic burden of cancer, 1985: United States and California. In: Scheffler R, Andrews N (eds) Cancer care and costs: DRGs and beyond. Health Administration Press Perspectives, Ann Arbor, Michigan Rice D, Hodgson T, Capell F (1989) The economic burden of cancer, 1985: United States and California. In: Scheffler R, Andrews N (eds) Cancer care and costs: DRGs and beyond. Health Administration Press Perspectives, Ann Arbor, Michigan
11.
go back to reference Gabrel C, Jones A (2000) The National Nursing Home Survey: 1997 Summary. National Center for Health Statistics. Vital Health Stat 13, vol 147, pp 1–121 Gabrel C, Jones A (2000) The National Nursing Home Survey: 1997 Summary. National Center for Health Statistics. Vital Health Stat 13, vol 147, pp 1–121
14.
go back to reference American Cancer Society, California Division and Public Health Institute, California Cancer Registry (2000) California cancer facts and figures 2001. American Cancer Society, California Division, Oakland, CA American Cancer Society, California Division and Public Health Institute, California Cancer Registry (2000) California cancer facts and figures 2001. American Cancer Society, California Division, Oakland, CA
17.
go back to reference US Census Bureau (2007) Statistical abstract of the United States: 2008 (127th edn). Washington, DC. Table 219 US Census Bureau (2007) Statistical abstract of the United States: 2008 (127th edn). Washington, DC. Table 219
18.
go back to reference Yabroff KR, Davis WW, Lamont EB et al (2007) Patient time costs associated with cancer care. J Natl Cancer Inst 99:14–23PubMedCrossRef Yabroff KR, Davis WW, Lamont EB et al (2007) Patient time costs associated with cancer care. J Natl Cancer Inst 99:14–23PubMedCrossRef
Metadata
Title
The economic burden of breast cancer in California
Authors
Wendy Max
Hai-Yen Sung
Brad Stark
Publication date
01-07-2009
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2009
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0149-4

Other articles of this Issue 1/2009

Breast Cancer Research and Treatment 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine